Pyrexia treatment of diffuse cutaneous leishmaniasis. 1971

R S Bray, and R W Ashford

UI MeSH Term Description Entries
D007897 Leishmaniasis, Mucocutaneous A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms. Leishmaniases, Mucocutaneous,Mucocutaneous Leishmaniases,Mucocutaneous Leishmaniasis
D010966 Plasmodium vivax A protozoan parasite that causes vivax malaria (MALARIA, VIVAX). This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions. Plasmodium vivaxs,vivax, Plasmodium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R S Bray, and R W Ashford
January 1970, Anais brasileiros de dermatologia,
R S Bray, and R W Ashford
January 1981, Medicina cutanea ibero-latino-americana,
R S Bray, and R W Ashford
May 1960, Hospital (Rio de Janeiro, Brazil),
R S Bray, and R W Ashford
January 1970, Transactions of the Royal Society of Tropical Medicine and Hygiene,
R S Bray, and R W Ashford
January 1983, Lancet (London, England),
R S Bray, and R W Ashford
January 1970, Transactions of the Royal Society of Tropical Medicine and Hygiene,
R S Bray, and R W Ashford
April 2009, Dermatology online journal,
R S Bray, and R W Ashford
September 1989, The American journal of tropical medicine and hygiene,
R S Bray, and R W Ashford
June 2006, International journal of dermatology,
R S Bray, and R W Ashford
January 2021, Anais brasileiros de dermatologia,
Copied contents to your clipboard!